{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:26:17Z","timestamp":1783477577095,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Unfallchirurg"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00113-015-0071-2","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T12:28:02Z","timestamp":1445344082000},"page":"913-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identifikation, Diagnostik und leitliniengerechte Osteoporosetherapie (DVO) unfallchirurgischer Patienten","Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients"],"prefix":"10.1007","volume":"118","author":[{"given":"C.","family":"Neuerburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schmidmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kammerlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"B\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mutschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"71_CR1","first-page":"998","volume":"171","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B, Eiken P, Eastell R (2011) Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 171:998\u20131004","journal-title":"Arch Intern Med"},{"key":"71_CR2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00198-009-1102-z","volume":"21","author":"LA Ahmed","year":"2010","unstructured":"Ahmed LA, Emaus N, Berntsen GK et al (2010) Bone loss and the risk of non-vertebral fractures in women and men: the Tromso study. Osteoporos Int 21:1503\u20131511","journal-title":"Osteoporos Int"},{"key":"71_CR3","unstructured":"Anonymous (2012) Leitlinienreport zur S3-Leitlinie: Bisphosphonat- assoziierte Kiefernekrose (BP-ONJ) und andere Medikamenten-assoziierte Kiefernekrosen AWMF-Register-Nr.\u00a0007\u2013091"},{"key":"71_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/17453671003761946","volume":"81","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Johansson T (2010) Teriparatide improves early callus formation in distal radial fractures. Acta orthopaedica 81:234\u2013236","journal-title":"Acta orthopaedica"},{"key":"71_CR5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00198-008-0814-9","volume":"20","author":"CJ Bacon","year":"2009","unstructured":"Bacon CJ, Gamble GD, Horne AM et al (2009) High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 20:1407\u20131415","journal-title":"Osteoporos Int"},{"key":"71_CR6","first-page":"500","volume":"810","author":"HA Bischoff-Ferrari","year":"2014","unstructured":"Bischoff-Ferrari HA (2014) Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 810:500\u2013525","journal-title":"Adv Exp Med Biol"},{"key":"71_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40\u201349","journal-title":"N Engl J Med"},{"key":"71_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1359\/jbmr.090826","volume":"25","author":"JA Cauley","year":"2010","unstructured":"Cauley JA, Parimi N, Ensrud KE et al (2010) Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res 25:545\u2013553","journal-title":"J Bone Miner Res"},{"issue":"2","key":"71_CR9","first-page":"S4","volume":"21","author":"C Cooper","year":"2010","unstructured":"Cooper C (2010) Osteoporosis: disease severity and consequent fracture management. Osteoporos Int 21(Suppl 2):S425\u2013429","journal-title":"Osteoporos Int"},{"key":"71_CR10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9","volume":"41","author":"WJ Dhert","year":"1998","unstructured":"Dhert WJ, Thomsen P, Blomgren AK et al (1998) Integration of press-fit implants in cortical bone: a study on interface kinetics. J Biomed Mater Res 41:574\u2013583","journal-title":"J Biomed Mater Res"},{"key":"71_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00223-014-9855-6","volume":"94","author":"J Ding","year":"2014","unstructured":"Ding J, Heller DA, Ahern FM et al (2014) The relationship between proton pump inhibitor adherence and fracture risk in the elderly. Calcif Tissue Int 94:597\u2013607","journal-title":"Calcif Tissue Int"},{"key":"71_CR12","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1055\/s-0031-1297267","volume":"136","author":"M Drey","year":"2011","unstructured":"Drey M, Bollheimer C (2011) [Vitamin D supplemention in the elderly]. Dtsch Med Wochenschr 136:2463\u20132465","journal-title":"Dtsch Med Wochenschr"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bone.2013.05.022","volume":"56","author":"A El Maghraoui","year":"2013","unstructured":"El Maghraoui A, Rezqi A, Mounach A et al (2013) Vertebral fractures and abdominal aortic calcification in postmenopausal women. A cohort study. Bone 56:213\u2013219","journal-title":"Bone"},{"key":"71_CR14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","volume":"24","author":"EF Eriksen","year":"2009","unstructured":"Eriksen EF, Lyles KW, Colon-Emeric CS et al (2009) Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res 24:1308\u20131313","journal-title":"J Bone Miner Res"},{"key":"71_CR15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10039-014-2100-8","volume":"16","author":"M F\u00f6rtsch","year":"2014","unstructured":"F\u00f6rtsch M, Schmidt T, Feldmann C et al (2014) DVO-Leitlinie (DVO: Dachverband Osteologie) in der osteologischen Schwerpunktpraxis. Trauma Berufskrankh 16:110\u2013121","journal-title":"Trauma Berufskrankh"},{"key":"71_CR16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00113-007-1258-y","volume":"110","author":"U Frerichmann","year":"2007","unstructured":"Frerichmann U, Raschke MJ, Stockle U et al (2007) [Proximal femoral fractures in the elderly. Data from health insurance providers on more than 23 million insured persons\u2013part 2]. Unfallchirurg 110:610\u2013616","journal-title":"Unfallchirurg"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bone.2006.09.026","volume":"40","author":"P Garnero","year":"2007","unstructured":"Garnero P, Munoz F, Sornay-Rendu E et al (2007) Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 40:716\u2013722","journal-title":"Bone"},{"key":"71_CR18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jbmr.1476","volume":"27","author":"S Gehlbach","year":"2012","unstructured":"Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res 27:645\u2013653","journal-title":"J Bone Miner Res"},{"key":"71_CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","volume":"58","author":"BJ Gertz","year":"1995","unstructured":"Gertz BJ, Holland SD, Kline WF et al (1995) Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 58:288\u2013298","journal-title":"Clin Pharmacol Ther"},{"key":"71_CR20","doi-asserted-by":"crossref","unstructured":"Haasters F, Prall WC, Himmler M et al (2015) [Prevalence and management of osteoporosis in trauma surgery: implementation of national guidelines during inpatient fracture treatment]. Unfallchirurg 118(2):138\u2013145. doi:10.1007\/s00113-013-2500-4","DOI":"10.1007\/s00113-013-2500-4"},{"key":"71_CR21","unstructured":"Hadji P, Klein S, Gothe H et al (2013) Epidemiologie der Osteoporose \u2013 Bone Evaluation Study: Eine Analyse von Krankenkassen-Routinedaten. Dtsch Arztebl International 110:52\u201357"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5414\/CP201931","volume":"51","author":"P Hadji","year":"2013","unstructured":"Hadji P, Klein S, Haussler B et al (2013) The bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in Germany. Int J Clin Pharmacol Ther 51:868\u2013872","journal-title":"Int J Clin Pharmacol Ther"},{"key":"71_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-006-0206-y","volume":"18","author":"B Haussler","year":"2007","unstructured":"Haussler B, Gothe H, Gol D et al (2007) Epidemiology, treatment and costs of osteoporosis in Germany \u2013 the BoneEVA Study. Osteoporos Int 18:77\u201384","journal-title":"Osteoporos Int"},{"key":"71_CR24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Ivergard M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136","journal-title":"Arch Osteoporos"},{"key":"71_CR25","doi-asserted-by":"crossref","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ 344:e3427","journal-title":"BMJ"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"71_CR27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0140-6736(89)91124-0","volume":"2","author":"MF Holick","year":"1989","unstructured":"Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 2:1104\u20131105","journal-title":"Lancet"},{"key":"71_CR28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00198-004-1718-y","volume":"16","author":"SA Jamal","year":"2005","unstructured":"Jamal SA, Leiter RE, Bayoumi AM et al (2005) Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int 16:534\u2013540","journal-title":"Osteoporos Int"},{"key":"71_CR29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"71_CR30","first-page":"1455","volume":"25","author":"E Kanterewicz","year":"2014","unstructured":"Kanterewicz E, Puigoriol E, Garcia-Barrionuevo J et al (2014) Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study. Osteoporos Int 25:1455\u20131464","journal-title":"Osteoporos Int"},{"key":"71_CR31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","volume":"94","author":"TY Kim","year":"2012","unstructured":"Kim TY, Ha YC, Kang BJ et al (2012) Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? J Bone Joint Surg Br 94:956\u2013960","journal-title":"J Bone Joint Surg Br"},{"key":"71_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2474-12-187","volume":"12","author":"L Kolios","year":"2011","unstructured":"Kolios L, Takur C, Moghaddam A et al (2011) Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density). BMC Musculoskelet Disord 12:187","journal-title":"BMC Musculoskelet Disord"},{"key":"71_CR33","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/jbmr.2279","volume":"29","author":"JR Lewis","year":"2014","unstructured":"Lewis JR, Barre D, Zhu K et al (2014) Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. J Bone Miner Res 29:2489\u20132497","journal-title":"J Bone Miner Res"},{"key":"71_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477\u2013501","journal-title":"Endocr Rev"},{"key":"71_CR35","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"71_CR36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2013.09.014","volume":"57","author":"M Maggio","year":"2013","unstructured":"Maggio M, Lauretani F, Ceda GP et al (2013) Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone 57:437\u2013442","journal-title":"Bone"},{"key":"71_CR37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","volume":"43","author":"MM Mcdonald","year":"2008","unstructured":"Mcdonald MM, Dulai S, Godfrey C et al (2008) Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. Bone 43:653\u2013662","journal-title":"Bone"},{"key":"71_CR38","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"71_CR39","first-page":"593","volume":"89","author":"A Nehme","year":"2003","unstructured":"Nehme A, Maalouf G, Tricoire JL et al (2003) [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study]. Rev Chir Orthop Reparatrice Appar Mot 89:593\u2013598","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"key":"71_CR40","unstructured":"Osteologie D (2014) DVO-Leitlinie 2014. http:\/\/www.dv-osteologie.org\/uploads\/Leitlinie%202014\/DVO-Leitlinie%20Osteoporose%202014%20Kurzfassung%20und%20Langfassung%2018.%2009.%202014.pdf"},{"key":"71_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00198-011-1574-5","volume":"23","author":"C Roux","year":"2012","unstructured":"Roux C, Goldstein JL, Zhou X et al (2012) Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. Osteoporos Int 23:277\u2013284","journal-title":"Osteoporos Int"},{"key":"71_CR42","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815\u20131822","journal-title":"JAMA"},{"key":"71_CR43","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00198-012-2115-6","volume":"24","author":"O Strom","year":"2013","unstructured":"Strom O, Jonsson B, Kanis JA (2013) Intervention thresholds for denosumab in the UK using a FRAX(R)-based cost-effectiveness analysis. Osteoporos Int 24:1491\u20131502","journal-title":"Osteoporos Int"},{"key":"71_CR44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJWH.S7322","volume":"2","author":"JA Sunyecz","year":"2010","unstructured":"Sunyecz JA (2010) Zoledronic acid infusion for prevention and treatment of osteoporosis. Int J Womens Health 2:353\u2013360","journal-title":"Int J Womens Health"},{"key":"71_CR45","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00198-012-2048-0","volume":"24","author":"M Tenne","year":"2013","unstructured":"Tenne M, Mcguigan F, Besjakov J et al (2013) Degenerative changes at the lumbar spine \u2013 implications for bone mineral density measurement in elderly women. Osteoporos Int 24:1419\u20131428","journal-title":"Osteoporos Int"},{"key":"71_CR46","first-page":"1120","volume":"100","author":"RE Willburger","year":"2003","unstructured":"Willburger RE, Knorth H (2003) Osteoporose der Wirbels\u00e4ule: Therapieoption und Pr\u00e4ventionsstrategien. Dtsch Arztebl Int 100:A-1120\u20131131 [Heft 17]","journal-title":"Dtsch Arztebl Int"},{"key":"71_CR47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5414\/CP201632","volume":"50","author":"V Ziller","year":"2012","unstructured":"Ziller V, Kostev K, Kyvernitakis I et al (2012) Persistence and compliance of medications used in the treatment of osteoporosis \u2013 analysis using a large scale, representative, longitudinal German database. Int J Clin Pharmacol Ther 50:315\u2013322","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Der Unfallchirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00113-015-0071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00113-015-0071-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00113-015-0071-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:49:39Z","timestamp":1558572579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00113-015-0071-2"}},"subtitle":["Ein Behandlungsalgorithmus","A Treatment algorithm"],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s00113-015-0071-2","relation":{},"ISSN":["0177-5537","1433-044X"],"issn-type":[{"value":"0177-5537","type":"print"},{"value":"1433-044X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}